6533b855fe1ef96bd12b1b9c
RESEARCH PRODUCT
Aflibercept in combination with irinotecan, fluorouracil and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal cancer (mCRC) patients: A phase II multicentric study
Côme LepageThierry LecomteFrançois-xavier Caroli-boscAlexandra Lapeyre-prostLysiane MartheyFlorence MaryJulien TaiebThomas AparicioJ. SigrandJérôme DesraméS. Racine DoatSimon PernotLaetitia DahanK. Le Malicotsubject
0301 basic medicineOncologymedicine.medical_specialtyColorectal cancerbusiness.industryHematologymedicine.diseaseIrinotecan03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyFluorouracil030220 oncology & carcinogenesisInternal medicinemedicineFOLFIRIFirst line chemotherapybusinessAfliberceptmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |